Skip to main content

Response Genetics to Partner with UCSF on Pancreatic Cancer Dx Development

NEW YORK (GenomeWeb News) - Response Genetics today said it will work with the University of California, San Francisco, on a two-year research study aimed at developing a diagnostic test kit for pancreatic cancer.
The company said the study will combine data from patient outcomes with genetic information from formalin-fixed paraffin-embedded samples of pancreatic tissue provided by UCSF.
Response Genetics will cover the costs of the project, while Margaret Tempero, deputy director of the UCSF Comprehensive Cancer Center, will lead the investigation.
"Diagnostics tests emerging from this collaboration would help physicians tailor treatment to the individual by using genetic information to identify patients who would most benefit from surgery or chemotherapy and radiation," Response Genetics President and CEO Kathleen Danenberg said in a statement.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.